Drug Profile
Research programme: osteoarthritis therapies - Galapagos/Servier
Latest Information Update: 12 May 2021
Price :
$50
*
At a glance
- Originator Galapagos NV; Servier
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoarthritis